Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
What is the impact of home non-invasive ventilation on the health-related quality of life of patients with chronic obstructive pulmonary disease? A systematic review.
Систематический обзорСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Breen Alison, Avsar Pinar, Moore Zena, O'Connor Tom, Nugent Linda, Patton Declan
Аннотация
OBJECTIVES: To ascertain the impact of home non-invasive ventilation (NIV) on the health-related quality of life (HRQL) of patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
DESIGN: Systematic review.
METHODS: A preliminary search of computerised databases (CINAHL, Medline, Clinical Key, Cochrane) was conducted in June 2021, without any limitations on publication date. Inclusion criteria focused on home NIV prescribed for patients with moderate-to-severe COPD. Identified papers were critically appraised for rigour and validity. Data were extracted, analysed, and a narrative synthesis completed.
RESULTS: The review included eight studies, including five randomised controlled trials. Variations in the HRQL scores meant that the data were difficult to collate. Nevertheless, the studies did indicate an overall improved HRQL for those using NIV at home.
CONCLUSION: This systematic review determines that home NIV does positively impact the HRQL of those with COPD. However, the limited quality of primary studies highlights the need for more in-depth research in this area to bring about optimal standardisation of clinical practice in relation to the use of NIV at home.
DESIGN: Systematic review.
METHODS: A preliminary search of computerised databases (CINAHL, Medline, Clinical Key, Cochrane) was conducted in June 2021, without any limitations on publication date. Inclusion criteria focused on home NIV prescribed for patients with moderate-to-severe COPD. Identified papers were critically appraised for rigour and validity. Data were extracted, analysed, and a narrative synthesis completed.
RESULTS: The review included eight studies, including five randomised controlled trials. Variations in the HRQL scores meant that the data were difficult to collate. Nevertheless, the studies did indicate an overall improved HRQL for those using NIV at home.
CONCLUSION: This systematic review determines that home NIV does positively impact the HRQL of those with COPD. However, the limited quality of primary studies highlights the need for more in-depth research in this area to bring about optimal standardisation of clinical practice in relation to the use of NIV at home.